<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://retacompare.com/news/retatrutide-side-effects-discussed-on-reddit-amid-glp-1-research</loc>
    <lastmod>2026-10-20T17:52:14.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T17:52:14.000Z</news:publication_date>
      <news:title>Retatrutide Side Effects Discussed on Reddit Amid GLP-1 Research</news:title>
      <news:keywords>Patient Experiences, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/factors-influencing-response-to-glp-1-agonists-in-obesity-treatment</loc>
    <lastmod>2026-10-20T17:30:59.251Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T17:30:59.251Z</news:publication_date>
      <news:title>Factors Influencing Response to GLP-1 Agonists in Obesity Treatment</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/glp-1r-agonism-s-role-in-breast-cancer-a-potential-metabolic-oncogenic-link</loc>
    <lastmod>2026-10-20T17:30:59.251Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T17:30:59.251Z</news:publication_date>
      <news:title>GLP-1R Agonism&apos;s Role in Breast Cancer: A Potential Metabolic-Oncogenic Link</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/teen-discusses-daily-life-changes-from-glp-1-medication-use</loc>
    <lastmod>2026-10-20T17:15:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T17:15:00.000Z</news:publication_date>
      <news:title>Teen Discusses Daily Life Changes from GLP-1 Medication Use</news:title>
      <news:keywords>Patient Experiences, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/retatrutide-s-potential-to-overcome-glp-1-weight-loss-challenges</loc>
    <lastmod>2026-10-20T14:03:06.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T14:03:06.000Z</news:publication_date>
      <news:title>Retatrutide&apos;s Potential to Overcome GLP-1 Weight-Loss Challenges</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/novo-s-obesity-drug-achieves-25-weight-loss-in-women-in-late-stage-trial</loc>
    <lastmod>2026-10-20T12:50:24.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T12:50:24.000Z</news:publication_date>
      <news:title>Novo&apos;s Obesity Drug Achieves 25% Weight Loss in Women in Late-Stage Trial</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/exploring-adult-weight-loss-drugs-for-pediatric-obesity-treatment</loc>
    <lastmod>2026-10-20T11:31:06.951Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T11:31:06.951Z</news:publication_date>
      <news:title>Exploring Adult Weight-Loss Drugs for Pediatric Obesity Treatment</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/tirzepatide-shows-promise-for-obstructive-sleep-apnea-and-cardiometabolic-health</loc>
    <lastmod>2026-10-20T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T00:00:00.000Z</news:publication_date>
      <news:title>Tirzepatide Shows Promise for Obstructive Sleep Apnea and Cardiometabolic Health</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/comparing-oral-and-injectable-incretin-based-anti-obesity-therapies</loc>
    <lastmod>2026-10-20T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T00:00:00.000Z</news:publication_date>
      <news:title>Comparing Oral and Injectable Incretin-Based Anti-Obesity Therapies</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/exploring-dose-response-in-incretin-and-multi-agonist-obesity-treatments</loc>
    <lastmod>2026-10-20T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T00:00:00.000Z</news:publication_date>
      <news:title>Exploring Dose-Response in Incretin and Multi-Agonist Obesity Treatments</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/ai-uncovers-insights-as-reddit-users-test-unapproved-weight-loss-drug</loc>
    <lastmod>2026-10-19T22:15:55.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-19T22:15:55.000Z</news:publication_date>
      <news:title>AI Uncovers Insights as Reddit Users Test Unapproved Weight-Loss Drug</news:title>
      <news:keywords>Patient Experiences, Retatrutide</news:keywords>
    </news:news>
  </url>
</urlset>
